314 related articles for article (PubMed ID: 10900408)
21. Combination of in vitro bioassays encompassing different mechanisms to determine the endocrine-disrupting effects of river water.
Oh SM; Park K; Chung KH
Sci Total Environ; 2006 Feb; 354(2-3):252-64. PubMed ID: 16398999
[TBL] [Abstract][Full Text] [Related]
22. Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.
van der Burg B; Winter R; Weimer M; Berckmans P; Suzuki G; Gijsbers L; Jonas A; van der Linden S; Witters H; Aarts J; Legler J; Kopp-Schneider A; Bremer S
Reprod Toxicol; 2010 Aug; 30(1):73-80. PubMed ID: 20435135
[TBL] [Abstract][Full Text] [Related]
23. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
[TBL] [Abstract][Full Text] [Related]
24. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.
Witters H; Freyberger A; Smits K; Vangenechten C; Lofink W; Weimer M; Bremer S; Ahr PH; Berckmans P
Reprod Toxicol; 2010 Aug; 30(1):60-72. PubMed ID: 20362049
[TBL] [Abstract][Full Text] [Related]
25. A new bioluminescent cellular assay to measure the transcriptional effects of chemicals that modulate the alpha-1 thyroid hormone receptor.
Jugan ML; Lévy-Bimbot M; Pomérance M; Tamisier-Karolak S; Blondeau JP; Lévi Y
Toxicol In Vitro; 2007 Sep; 21(6):1197-205. PubMed ID: 17532181
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
Ishibashi O; Yamagishi T; Hanada K; Kawashima H
Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
[TBL] [Abstract][Full Text] [Related]
27. A rapid and sensitive high throughput reporter gene assay for estrogenic effects of environmental contaminants.
Edmunds JS; Fairey ER; Ramsdell JS
Neurotoxicology; 1997; 18(2):525-32. PubMed ID: 9291500
[TBL] [Abstract][Full Text] [Related]
28. [Bioassay of recombinant green fluorescent protein gene yeast cell for a high throughput to screen estrogenic compounds].
Li X; Luo F; Wang X; Jia P; Zhang J; Zhu P; Zhang W
Sheng Wu Gong Cheng Xue Bao; 2008 Dec; 24(12):2093-7. PubMed ID: 19306581
[TBL] [Abstract][Full Text] [Related]
29. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
[TBL] [Abstract][Full Text] [Related]
30. The application of reporter gene assays for the detection of endocrine disruptors in sport supplements.
Plotan M; Elliott CT; Scippo ML; Muller M; Antignac JP; Malone E; Bovee TF; Mitchell S; Connolly L
Anal Chim Acta; 2011 Aug; 700(1-2):34-40. PubMed ID: 21742114
[TBL] [Abstract][Full Text] [Related]
31. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection.
Michelini E; Leskinen P; Virta M; Karp M; Roda A
Biosens Bioelectron; 2005 May; 20(11):2261-7. PubMed ID: 15797324
[TBL] [Abstract][Full Text] [Related]
32. Development of a simple screening system for endocrine disruptors.
Sugawara T; Nakajima A; Nomura E
Med Sci Monit; 2002 Nov; 8(11):BR431-8. PubMed ID: 12444367
[TBL] [Abstract][Full Text] [Related]
33. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor.
Blankvoort BM; de Groene EM; van Meeteren-Kreikamp AP; Witkamp RF; Rodenburg RJ; Aarts JM
Anal Biochem; 2001 Nov; 298(1):93-102. PubMed ID: 11673900
[TBL] [Abstract][Full Text] [Related]
34. Induction of an estrogen-responsive reporter gene in rainbow trout hepatoma cells (RTH 149) at 11 or 18 degrees C.
Hornung MW; Ankley GT; Schmieder PK
Environ Toxicol Chem; 2003 Apr; 22(4):866-71. PubMed ID: 12685723
[TBL] [Abstract][Full Text] [Related]
35. Estrogenic and androgenic activity of PCBs, their chlorinated metabolites and other endocrine disruptors estimated with two in vitro yeast assays.
Svobodová K; Placková M; Novotná V; Cajthaml T
Sci Total Environ; 2009 Nov; 407(22):5921-5. PubMed ID: 19716585
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of estrogenic activities of pesticides using an in vitro reporter gene assay.
Kojima M; Fukunaga K; Sasaki M; Nakamura M; Tsuji M; Nishiyama T
Int J Environ Health Res; 2005 Aug; 15(4):271-80. PubMed ID: 16175743
[TBL] [Abstract][Full Text] [Related]
37. Assessment of estrogenic activity in some common essential oil constituents.
Howes MJ; Houghton PJ; Barlow DJ; Pocock VJ; Milligan SR
J Pharm Pharmacol; 2002 Nov; 54(11):1521-8. PubMed ID: 12495555
[TBL] [Abstract][Full Text] [Related]
38. GFP-reporter for a high throughput assay to monitor estrogenic compounds.
Beck V; Pfitscher A; Jungbauer A
J Biochem Biophys Methods; 2005 Jul; 64(1):19-37. PubMed ID: 15992933
[TBL] [Abstract][Full Text] [Related]
39. In vitro estrogenic activity of formononetin by two bioassay systems.
Ji ZN; Zhao WY; Liao GR; Choi RC; Lo CK; Dong TT; Tsim KW
Gynecol Endocrinol; 2006 Oct; 22(10):578-84. PubMed ID: 17135037
[TBL] [Abstract][Full Text] [Related]
40. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
